Drug Profile
Binimetinib companion diagnostic - Qiagen
Latest Information Update: 02 Aug 2019
Price :
$50
*
At a glance
- Originator QIAGEN
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Malignant melanoma